Moderna Reports Positive Phase 3 Data For Flu And COVID Combination Vaccine

Moderna, Inc. (MRNA) announced Monday that its Phase 3 trial of mRNA-1083, an investigational combination vaccine against influenza and COVID-19, has met its primary endpoints. Moderna is the only company with a positive Phase 3 flu and COVID combination vaccine. mRNA-1083 elicited higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID...

Read More

SciSparc secures Canadian patent for pain treatment

TEL AVIV - SciSparc Ltd. (NASDAQ:SPRC), a pharmaceutical company specializing in central nervous system disorders and rare diseases, has received a Canadian patent for a novel combination of opioids and n-acylethanolamines intended for pain management. The Canadian Intellectual Property Office granted the patent, signaling a potential advancement in the approach to treating chronic pain amid...

Read More